Authors:
Cornely, OA
Chemnitz, J
Brochhagen, HG
Lemmer, K
Schutt, H
Sohngen, D
Staib, P
Wickenhauser, C
Diehl, V
Tintelnot, K
Citation: Oa. Cornely et al., Disseminated Neocosmospora vasinfecta infection in a patient with acute nonlymphocytic leukemia, EM INFECT D, 7(1), 2001, pp. 149-152
Citation: M. Reiser et al., Primary lymphoma of the conjunctiva - a rare manifestation of indolent non-Hodgkin's lymphoma, ANN HEMATOL, 80(5), 2001, pp. 311-313
Authors:
Thiele, J
Kvasnicka, HM
Zankovich, R
Diehl, V
Citation: J. Thiele et al., Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis, ANN HEMATOL, 80(3), 2001, pp. 160-165
Authors:
Draube, A
Pfister, R
Vocherodt, M
Schuster, S
Kube, D
Diehl, V
Tesch, H
Citation: A. Draube et al., Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement, ANN HEMATOL, 80(2), 2001, pp. 83-89
Authors:
Cornely, OA
Bethe, U
Salzberger, B
Franzen, C
Hartmann, P
Steinmetz, T
Fatkenheuer, G
Seifert, H
Diehl, V
Schrappe, M
Citation: Oa. Cornely et al., Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever, ANN HEMATOL, 80(2), 2001, pp. 103-108
Authors:
Rueffer, U
Breuer, K
Josting, A
Lathan, B
Sieber, M
Manzke, O
Grotenhermen, FJ
Tesch, H
Bredenfeld, H
Koch, P
Nisters-Backes, H
Wolf, J
Engert, A
Diehl, V
Citation: U. Rueffer et al., Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment, ANN ONCOL, 12(9), 2001, pp. 1307-1311
Authors:
Borchmann, P
Schnell, R
Knippertz, R
Staak, JO
Camboni, GM
Bernareggi, A
Hubel, K
Staib, P
Schulz, A
Diehl, V
Engert, A
Citation: P. Borchmann et al., Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma, ANN ONCOL, 12(5), 2001, pp. 661-667
Authors:
Pfreundschuh, M
Hasenclever, D
Loeffler, M
Ehninger, G
Schmitz, N
Kirchner, H
Koch, P
Lathan, B
Rueffer, U
Sextro, M
Franklin, J
Tesch, H
Diehl, V
Citation: M. Pfreundschuh et al., Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF, ANN ONCOL, 12(4), 2001, pp. 471-477
Citation: Fb. Hagemeister et V. Diehl, The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomas, EUR J HAEMA, 66, 2001, pp. 1-2
Authors:
Kvasnicka, HM
Thiele, J
Schmitt-Graeff, A
Diehl, V
Zankovich, R
Niederle, N
Leder, LD
Schafer, HE
Citation: Hm. Kvasnicka et al., Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph1+ chronic myelogenous leukemia: A multicenter trial, J CL ONCOL, 19(12), 2001, pp. 2994-3009
Authors:
Duhmke, E
Franklin, J
Pfreundschuh, M
Sehlen, S
Willich, N
Ruhl, U
Muller, RP
Lukas, P
Atzinger, A
Paulus, U
Lathan, B
Ruffer, U
Sieber, M
Wolf, J
Engert, A
Georgii, A
Staar, S
Herrmann, R
Beykirch, M
Kirchner, H
Emminger, A
Greil, R
Fritsch, E
Koch, P
Drochtert, A
Brosteanu, O
Hasenclever, D
Loeffler, M
Diehl, V
Citation: E. Duhmke et al., Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone, J CL ONCOL, 19(11), 2001, pp. 2905-2914
Authors:
Weihrauch, MR
Rabe, K
Kochanek, M
Tesch, H
Diehl, V
Wolf, J
Citation: Mr. Weihrauch et al., Factitious disorders. hematological, neurological and dermatological symptoms in a physician with factitious disorder - Case report and literature review, MED KLIN, 96(9), 2001, pp. 555-560
Authors:
Thiele, J
Kvasnicka, HM
Zankovich, R
Diehl, V
Citation: J. Thiele et al., The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias, HAEMATOLOG, 86(4), 2001, pp. 368-374
Authors:
Ansen, S
Engert, A
Wolf, J
Sieber, M
Paulus, U
Diehl, V
Citation: S. Ansen et al., German Hodgkin's Lymphoma Study Group (DHSG): 20 years experience with diagnostics, therapy and aftercare in patients with Hodgkin's disease, ONKOLOGIE, 24, 2001, pp. 35-48
Authors:
Re, D
Benenson, E
Beyer, M
Gresch, O
Draube, A
Diehl, V
Wolf, J
Citation: D. Re et al., Cell fusion is not involved in the generation of giant cells in the Hodgkin-Reed Sternberg cell line L1236, AM J HEMAT, 67(1), 2001, pp. 6-9
Authors:
Thiele, J
Kvasnicka, HM
Muehlhausen, K
Walter, S
Zankovich, R
Diehl, V
Citation: J. Thiele et al., Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients, PATH RES PR, 197(2), 2001, pp. 77-84
Authors:
Manzke, O
Russello, O
Leenen, C
Diehl, V
Bohlen, H
Berthold, F
Citation: O. Manzke et al., Immunotherapeutic strategies in neuroblastoma: Antitumoral activity of deglycosylated ricin A conjugated anti-CD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies, MED PED ONC, 36(1), 2001, pp. 185-189